Factor V Leiden and postoperative deep vein thrombosis in patients undergoing open Roux-en-Y gastric bypass surgery

Obesity Surgery

Volumn 15, Issue 4, 2005, Pages 561-564

  Atluri, Pavan ^a   Raper, Steven E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; Deep vein thrombosis; Factor V Leiden; Gastric bypass; Morbid obesity

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; CARDIOVASCULAR RISK; CASE REPORT; COMORBIDITY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; MALE; MORBID OBESITY; POINT MUTATION; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; THROMBOPHLEBITIS; VEIN THROMBOSIS; VENA CAVA FILTER;

ADULT; ANASTOMOSIS, ROUX-EN-Y; BODY MASS INDEX; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; ILIAC VEIN; MALE; OBESITY, MORBID; POINT MUTATION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PULMONARY EMBOLISM; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENA CAVA FILTERS; VENOUS THROMBOSIS;

EID: 18044387382     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892053723312     Document Type: Review

References (15)

1. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000; 10: 7-14.
2. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-175S.
3. Mateo J, Oliver A, Borrell M et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia. Thromb Haemost 1997; 77: 444-51.
4. Zoller B, Svensson PJ, He X et al. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4.
5. Ridker PM, Miletich JP, Hennekens CH et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277: 1305-7.
6. Eriksonn S, Backman L, Ljungstrom KG. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg 1997; 7: 332-5.
7. Sapala JA, Wood MH, Schuhknecht MP et al. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 2003; 13: 819-25.
8. Gleysteen JJ, Bandyk DF, Hussey CV et al. Perioperative coagulation changes with gastric bypass: association with venous thrombosis? Obes Surg 1993; 3: 7-14.
9. Nguyen NT, Owings JT, Gosselin R et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 2001; 136: 909-16.
10. Blasyk H, Wollan PC, Witkiewicz AK et al. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch 1999; 434: 529-32.
11. Blaszyk H, Bjornsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg. 2000; 135: 1410-3.
12. Melinek J, Livingston E, Cortina G et al. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Path Lab Med 2002; 126: 1091-5.
13. Greenfield LJ, Proctor MC. Current indications for caval interruption; should they be liberalized in view of improving technology? Semin Vasc Surg 1996; 9: 50-8.
14. Young N. Clinical follow-up of patients with percutaneously inserted inferior vena caval filters. Australas Radiol 1995; 39: 233-6.
15. Ferrell A, Byrne TK, Robison JG. Placement of inferior vena cava filters in bariatric surgical patients - possible indications and technical considerations. Obes Surg 2004; 14: 738-43.